Search results
Results from the WOW.Com Content Network
As of 2024, she is an emeritus professor at Scripps Research, and serves on the advisory boards of the La Jolla Institute for Immunology and the San Diego Biomedical Research Institute. [3] [4] Her research has focused on immune tolerance and autoimmunity, particularly type 1 diabetes, as well as the immune response to tumors.
Matzinger is chief of the T-Cell Tolerance and Memory Section at the U.S. National Institute of Allergy and Infectious Diseases (NIAID). [6] The lab has been referred to as the "Ghost Lab" for Matzinger's choice to conduct the first nine months of her research alone with a focus on chaos theory.
La Jolla Institute for Immunology (LJI) is a non-profit research organization in La Jolla, a community of San Diego, California. The institute was founded in 1988. It is located in UC San Diego’s Research Park. The institute researches immunology and immune system diseases.
Gregory Michael Fahy [1] is a California-based cryobiologist, biogerontologist, and businessman. He is Vice President and Chief Scientific Officer at 21st Century Medicine, Inc, and has co-founded Intervene Immune, a company developing clinical methods to reverse immune system aging. [2] He was the 2022–2023 president of the Society for ...
Immune tolerance encompasses the range of physiological mechanisms by which the body reduces or eliminates an immune response to particular agents. It is used to describe the phenomenon underlying discrimination of self from non-self, suppressing allergic responses, allowing chronic infection instead of rejection and elimination, and preventing ...
The Complaint Resolution Program helps resolve complaints that consumers have filed after experiencing difficulty or disappointment in the California marketplace. The Consumer information Center is DCA's information resource center for consumers and licensees. Through its Call Center and Correspondence Unit, CIC provides consumers and licensees ...
The lack of naïve T lymphocytes is the cause of low plasticity of the immune system in the elderly. [11] In aging of the immune system is also a decrease in central tolerance and an increase in the number of autoreactive T cells. [12] B cells also have a decreased repertoire of naïve cells and an increase in memory B cells. [13]
Tolerogenic therapy aims to induce immune tolerance where there is pathological or undesirable activation of the normal immune response.This can occur, for example, when an allogeneic transplantation patient develops an immune reaction to donor antigens, or when the body responds inappropriately to self antigens implicated in autoimmune diseases. [1]